Tina Larson
President chez RECURSION PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/03/2024
Profil
Actuellement, Tina Larson occupe le poste de présidente et directrice de l'exploitation de Recursion Pharmaceuticals, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/03/2024 | 639 982 ( 0,31% ) | 6 M $ | 31/03/2024 |
Postes actifs de Tina Larson
| Sociétés | Poste | Début |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | President | 01/10/2019 |
Revagenix , Inc.
 Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Chairman | - |
Anciens postes connus de Tina Larson
| Sociétés | Poste | Fin |
|---|---|---|
| ACHAOGEN | Corporate Officer/Principal | 01/06/2018 |
| Roche, Inc. | Corporate Officer/Principal | 01/04/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Tina Larson
| Colorado State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche, Inc. | |
Revagenix , Inc.
Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Health Technology |
